HIGHLIGHTS
- who: Patricia Iranzo from the University of Texas MD Anderson Cancer Center, United States have published the article: Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer, in the Journal: (JOURNAL)
SUMMARY
Tumor cells escape to the antitumor immune_response using different mechanisms involving antigens, cytokines and immune checkpoint proteins. Understanding tumor immunology must be achieved through the integration of local immune_response in the tumor microenvironment with the changes in the peripheral immune system. Immunity in cancer is regulated by diverse cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.